Read More Healthcare Industry News Axogen funds $200m BioCircuit acquisition with a $208.7m equity offering Axogen is acquiring BioCircuit Technologies for $200 million in cash while issuing 4.91 million new shares at $42.50 to finance the deal, linking NerveTape expansion directly to shareholder dilution. byVenkateshSeptember 19, 2026